Investor Presentaiton slide image

Investor Presentaiton

Solid organic growth of 8% in H1 2022/23 with solid momentum across business areas and geographies, excluding China H1 2022/23 revenue by business area H1 2022/23 revenue by geography Business area Ostomy Care Continence Care Reported revenue FY DKKm Organic growth Share of organic Geographic FY growth area 4,478 7% 36% European markets 6% 29% 3,951 Reported revenue FY DKKm FY Organic growth Share of organic growth 6,878 6% 43% Voice & 9% 3% Respiratory Care* 959 Other developed markets 3,187 11% 36% Wound & Skin 1,425 7% 12% Care Emerging markets 2,101 9% 21% Interventional 1,353 14% 20% Urology Coloplast Group *Part of organic growth since February 1, 2023 54 12,166 8% 100% Coloplast Group 12,166 8% 100% Coloplast
View entire presentation